Float Short %

14.58

Margin Of Safety %

Put/Call OI Ratio

0.69

EPS Next Q Diff

-0.2

EPS Last/This Y

-0.83

EPS This/Next Y

2.38

Price

24.72

Target Price

48.95

Analyst Recom

2.89

Performance Q

-26.79

Relative Volume

0.59

Beta

1.99

Ticker: MRNA

22 items of 1

Date	Symbol	Last	P/C OI	P/C Vol	Total OI
2025-03-19	MRNA	33.33	0.77	0.55	872983
2025-03-20	MRNA	32.47	0.76	0.29	879279
2025-03-21	MRNA	32.62	0.74	1.05	888782
2025-03-24	MRNA	34.25	0.82	0.53	713902
2025-03-25	MRNA	33.86	0.80	0.72	743703
2025-03-26	MRNA	31.5	0.80	1.46	750706
2025-03-27	MRNA	32.28	0.81	0.14	762886
2025-03-28	MRNA	31.08	0.73	0.86	823164
2025-03-31	MRNA	28.35	0.82	1.30	751106
2025-04-01	MRNA	27.14	0.82	0.30	779033
2025-04-02	MRNA	27.72	0.82	1.10	802504
2025-04-03	MRNA	25.7	0.82	0.45	815074
2025-04-04	MRNA	25.1	0.82	0.61	826607
2025-04-07	MRNA	25.6	0.81	0.85	798494
2025-04-08	MRNA	24.65	0.79	0.61	814859
2025-04-09	MRNA	26.68	0.78	0.75	826485
2025-04-10	MRNA	24.48	0.77	0.76	837915
2025-04-11	MRNA	26.15	0.73	0.11	858035
2025-04-14	MRNA	26.79	0.72	0.29	833640
2025-04-15	MRNA	26.25	0.72	1.08	848814
2025-04-16	MRNA	24.99	0.72	0.26	856907
2025-04-17	MRNA	24.72	0.69	0.21	858254
Date	Symbol	Last	P/C OI	P/C Vol	Total OI

22 items 1 of 1

22 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2025-03-19	MRNA	33.32	0.1	-488.0	-10.25
2025-03-20	MRNA	32.45	0.1	-391.9	-10.11
2025-03-21	MRNA	32.66	0.1	-659.0	-10.13
2025-03-24	MRNA	34.17	0.0	-990.4	-10.13
2025-03-25	MRNA	33.85	0.0	-530.0	-10.16
2025-03-26	MRNA	31.48	0.0	-41.5	-10.16
2025-03-27	MRNA	32.23	0.0	-810.7	-10.16
2025-03-28	MRNA	31.12	0.0	-341.3	-10.16
2025-03-31	MRNA	28.35	0.0	174.8	-10.16
2025-04-01	MRNA	27.16	0.0	-193.0	-10.16
2025-04-02	MRNA	27.72	0.0	-819.4	-10.16
2025-04-03	MRNA	25.73	0.0	120.8	-10.16
2025-04-04	MRNA	25.12	0.0	-335.3	-10.16
2025-04-07	MRNA	25.65	0.0	-859.9	-10.18
2025-04-08	MRNA	24.64	-0.8	-159.8	-10.18
2025-04-09	MRNA	26.67	-0.8	-1616.6	-10.18
2025-04-10	MRNA	24.48	-0.8	274.3	-10.18
2025-04-11	MRNA	26.15	-1.0	-1441.1	-10.18
2025-04-14	MRNA	26.80	-1.0	-856.9	-10.18
2025-04-15	MRNA	26.24	-1.0	-382.6	-10.18
2025-04-16	MRNA	25.19	-0.9	-164.5	-10.11
2025-04-17	MRNA	24.72	-0.9	-382.8	-10.11
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

22 items 1 of 1

22 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2025-03-19	MRNA	0.43	7.24	13.19
2025-03-20	MRNA	0.43	7.24	13.19
2025-03-21	MRNA	0.43	7.24	13.19
2025-03-24	MRNA	0.43	7.35	13.19
2025-03-25	MRNA	0.43	7.35	13.19
2025-03-26	MRNA	0.43	7.35	13.72
2025-03-27	MRNA	0.43	7.35	13.72
2025-03-28	MRNA	0.43	7.35	13.72
2025-03-31	MRNA	0.43	7.33	13.72
2025-04-01	MRNA	0.43	7.33	13.72
2025-04-02	MRNA	0.43	7.33	13.72
2025-04-03	MRNA	0.43	7.33	13.72
2025-04-04	MRNA	0.43	7.33	13.72
2025-04-07	MRNA	0.43	7.34	13.72
2025-04-08	MRNA	0.43	7.34	13.72
2025-04-09	MRNA	0.43	7.34	13.72
2025-04-10	MRNA	0.43	7.34	14.58
2025-04-11	MRNA	0.43	7.34	14.58
2025-04-14	MRNA	0.43	7.34	14.58
2025-04-15	MRNA	0.43	7.34	14.58
2025-04-16	MRNA	0.43	7.34	14.58
2025-04-17	MRNA	0.43	7.34	14.58
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

22 items 1 of 1

Last Quarter Act. EPS

-2.91

Avg. EPS Est. Current Quarter

-3.14

Avg. EPS Est. Next Quarter

-3.11

Insider Transactions

0.43

Institutional Transactions

7.34

Beta

1.99

Average Sales Estimate Current Quarter

130

Average Sales Estimate Next Quarter

118

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

-94.9

Target Price

48.95

P/E

Forward P/E

PEG

P/S

2.95

P/B

0.88

P/Free Cash Flow

EPS

-9.28

Average EPS Est. Cur. Y

-10.11

EPS Next Y. (Est.)

-7.73

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-110.04

Relative Volume

0.59

Return on Equity vs Sector %

-52.2

Return on Equity vs Industry %

-39.2

EPS 1 7Days Diff

0.1

EPS 1 30Days Diff

0.14

EBIT Estimation

-382.8

Moderna, Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 5800

Moderna, Inc., a biotechnology company, provides messenger RNA medicines in the United States, Europe, and internationally. The company's respiratory vaccines include spikevax, mRESVIA, COVID, RSV, seasonal influenza, combination, and pandemic influenza vaccine; latent vaccines comprise cytomegalovirus, epstein-barr virus, herpes simplex virus, varicella zoster virus, and human immunodeficiency virus vaccines; enteric viruses include norovirus; public health vaccines consist of Zika, Nipah, and Mpox vaccines; and bacterial diseases vaccines, such as lyme vaccines. It also provides oncology therapeutics, such as individualized neoantigen and checkpoint adaptive immune modulation therapy; and rare disease products, including propionic and methylmalonic acidemia, glycogen storage disease type 1a, ornithine transcarbamylase deficiency, phenylketonuria, crigler-najjar syndrome type 1, and cystic fibrosis. It has strategic alliances and collaborations with AstraZeneca; Merck & Co., Inc; Vertex Pharmaceuticals Incorporated; Vertex Pharmaceuticals (Europe) Limited; Generation Bio Co.; immatics N.V.; Life Edit Therapeutics; Carisma Therapeutics, Inc.; CytomX Therapeutics; Defense Advanced Research Projects Agency; Biomedical Advanced Research and Development Authority; Institute for Life Changing Medicines; The Bill & Melinda Gates Foundation; and OpenAI. The company was formerly known as Moderna Therapeutics, Inc. and changed its name to Moderna, Inc. in August 2018. Moderna, Inc. was founded in 2010 and is headquartered in Cambridge, Massachusetts.

stock quote shares MRNA – Moderna, Inc. Stock Price stock today

news today MRNA – Moderna, Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch MRNA – Moderna, Inc. yahoo finance google finance

stock history MRNA – Moderna, Inc. invest stock market

stock prices MRNA premarket after hours

ticker MRNA fair value insiders trading

Investment involves risk. As a general rule, you should only trade in financial products that you are familiar with and understand the risk associated with them. The risk warning described in each financial product below is not exhaustive, you should carefully consider your investment experience, financial situation, investment objective, risk tolerance level and consult your independent financial adviser as to the suitability of your situation prior making any investment.

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Relative Volume

Beta

Ticker: MRNA

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Get Started

About

Last Quarter Act. EPS

Average EPS Est. Cur. Y